Bionano Genomics Inc
NASDAQ:BNGO

Watchlist Manager
Bionano Genomics Inc Logo
Bionano Genomics Inc
NASDAQ:BNGO
Watchlist
Price: 1.505 USD -1.63% Market Closed
Market Cap: $15.3m

Operating Margin

-127.5%
Current
Improving
by 196.4%
vs 3-y average of -323.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-127.5%
=
Operating Income
$-36.6m
/
Revenue
$28.7m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-127.5%
=
Operating Income
$-36.6m
/
Revenue
$28.7m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Bionano Genomics Inc
NASDAQ:BNGO
14.7m USD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
236.2B USD
Loading...
US
Danaher Corp
NYSE:DHR
166.4B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
83T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
38.3B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
41.4B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
276.7B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.7B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.3B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.9B EUR
Loading...

Market Distribution

Lower than 86% of companies in the United States of America
Percentile
14th
Based on 14 112 companies
14th percentile
-127.5%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Bionano Genomics Inc
Glance View

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The company is headquartered in San Diego, California and currently employs 299 full-time employees. The company went IPO on 2018-08-01. The firm offers diagnostic services to physicians specializing in medical management for individuals with genetic conditions, such as pediatric neurodevelopmental disorders, including autism spectrum disorders. The company markets and sell the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation. Its Lineagen business provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, it offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view.

BNGO Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-127.5%
=
Operating Income
$-36.6m
/
Revenue
$28.7m
What is Bionano Genomics Inc's current Operating Margin?

The current Operating Margin for Bionano Genomics Inc is -127.5%, which is above its 3-year median of -323.8%.

How has Operating Margin changed over time?

Over the last 3 years, Bionano Genomics Inc’s Operating Margin has increased from -469.1% to -127.5%. During this period, it reached a low of -472.7% on Mar 31, 2023 and a high of -127.5% on Sep 30, 2025.

Back to Top